Cargando…
Proprotein convertase PCSK9 affects expression of key surface proteins in human pancreatic beta cells via intracellular and extracellular regulatory circuits
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the degradation of the low-density lipoprotein receptor. PCSK9 also targets proteins involved in lipid metabolism (very low–density lipoprotein receptor), immunity (major histocompatibility complex I), and viral infection (cluster...
Autores principales: | Saitoski, Kevin, Ryaboshapkina, Maria, Hamza, Ghaith M., Jarnuczak, Andrew F., Berthault, Claire, Carlotti, Françoise, Armanet, Mathieu, Sengupta, Kaushik, Underwood, Christina Rye, Andersson, Shalini, Guillas, Isabelle, Le Goff, Wilfried, Scharfmann, Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251788/ https://www.ncbi.nlm.nih.gov/pubmed/35660019 http://dx.doi.org/10.1016/j.jbc.2022.102096 |
Ejemplares similares
-
Characterization of the Secretome, Transcriptome, and Proteome of Human β Cell Line EndoC-βH1
por: Ryaboshapkina, Maria, et al.
Publicado: (2022) -
Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity()
por: Shin, Kyungsoo, et al.
Publicado: (2013) -
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
por: Schulz, Rainer, et al.
Publicado: (2015) -
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
por: O’Connell, Emma M., et al.
Publicado: (2020) -
Discovery of the Proprotein Convertases and their Inhibitors
por: Khatib, Abdel-Majid, et al.
Publicado: (2006)